0001474064-13-000002.txt : 20130107 0001474064-13-000002.hdr.sgml : 20130107 20130107160919 ACCESSION NUMBER: 0001474064-13-000002 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130107 FILED AS OF DATE: 20130107 DATE AS OF CHANGE: 20130107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nader Francois CENTRAL INDEX KEY: 0001365343 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 13515403 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 4/A 1 edgar.xml PRIMARY DOCUMENT X0306 4/A 2013-01-07 2012-12-26 0000890465 NPS PHARMACEUTICALS INC NPSP 0001365343 Nader Francois 550 HILLS DRIVE BEDMINSTER NJ 07921 0 1 0 0 President & CEO Common Stock 2012-12-21 4 J 0 30450 A 165111 D On February 7, 2012, the reporting person was awarded 60,900 restricted stock units under the 2005 Omnibus Incentive Plan with each restricted stock unit representing a contingent right to receive one share of NPS Pharmaceuticals, Inc.'s (the "Company") common stock upon the satisfaction of the following performance criteria: (i) one half of the restricted stock units will vest upon FDA approval of GATTEX and (ii) one half will vest upon FDA approval of NATPARA, with no shares being able to be earned after July 31, 2014. The FDA approved GATTEX, resulting in vesting of 30,450 restricted stock units and the payment to the reporting person of 30,450 shares of the Company's common stock on December 21, 2012. The vesting of these restricted stock units was omitted from the reporting person's Form 4 filed on December 26, 2012. Includes 1,043 shares acquired under the Company's employee stock purchase plan on March 30, 2012 and 928 shares acquired under the Company's employee stock purchase plan on September 30, 2012. /s/ Francois Nader, by Edward Stratemeier as Attorney-In-Fact 2013-01-07